Walt Disney: Analysts Anticipate $15.87 Billion In Q2 Revenue

Walt Disney (NYSE: DIS) will be reporting their fiscal second-quarter financial results today after market close. Analysts have a consensus $209.81 12-month price target on the company, via a total of 29 analysts, with six analysts having strong buy ratings, 17 analysts having buy ratings and six analysts have hold ratings. The street high comes from Atlantic Equities with a $230 price target, and the lowest target sits at $147 from Cowen and Company.

22 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 22 analysts is $15.87 billion; this number has been slightly revised downwards from $16.477 billion at the start of the year. The highest revenue estimate is $16.99 billion, while the lowest is $14.937 billion.

The analyst consensus for net income for the second quarter is $533.54 million, this is down from the start of the year at $599.52 million. The highest net income estimate is $1.095 billion, while the lowest is ($105) million.

Onto EBITDA estimates, there are currently 11 analysts who have second-quarter EBITDA estimates. The mean is currently $1.824 billion, with this number having been revised down from $2.255 billion at the start of the year. The street high estimate currently sits at $2.31 billion in EBITDA and the lowest is $1.132 billion.

Analysts estimate that quarterly earnings per share will come in at $0.01, with this number being revised lower since the start of the year. The street high is $0.35and the lowest estimate is ($0.32) per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

BMO Drops Kinross Gold’s Price Target On Messy Q1 Results

On Monday Kinross Gold (TSX: K) reported its first quarter financial results. The company saw...

Thursday, May 12, 2022, 12:24:00 PM

Dollarama: Canaccord Lifts Target To $72

Dollarama Inc (TSX: DOL) recently reported its fiscal first-quarter financial results for 2023, ending May...

Saturday, June 25, 2022, 05:06:00 PM

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Trulieve: Canaccord Reiterates $97 Price Target After Virtual Roadshow

Over the last week, Trulieve Cannabis (CSE: TRUL) went on a virtual roadshow mainly focused...

Tuesday, July 6, 2021, 04:04:00 PM

McDonalds: BMO Upgrades Firm Off Back Of Strong Earnings

On July 28, McDonald’s Corp (NYSE: MCD) reported their second quarter financial results. The company...

Sunday, August 1, 2021, 04:16:00 PM